Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
clinical trials
fda
5
×
life sciences
national blog main
national top stories
san francisco blog main
biotech ipos
new york blog main
new york top stories
san francisco top stories
alexion pharmaceuticals
boston
cancer
cancer drugs
cancer immunotherapy
deals
eli lilly
europe blog main
european society for medical oncology
hepatitis b
investing
medicare
mirati therapeutics
national
nonalcoholic steatohepatitis
89bio
abbvie
acute myeloid leukemia
adrian krainer
aligos therapeutics
alnylam pharmaceuticals
alx oncology
alzheimer europe conference
alzheimer's disease
astrazeneca
autoimmune diseases
bain capital
What
research
5
×
biotech
drug
medicines
companies
ipo
ipos
new
week
alzheimer’s
annual
arrival
assessed
attention
bio
biotechs
black
cancer
caught
causing
central
clinic
cns
communities
conference
days
diamond
dicerna
disease
disorder
drugs
eluded
emerged
esmo
europe
eye
gene
germany
hasn’t
hepatitis
Language
unset
Current search:
fda
×
biotech
×
research
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More